{"schemaVersion":"peptidescanner-evidence-object/v1","objectId":"story:pubmed-pmid-41083011-semaglutide:v1","objectPathId":"pubmed-pmid-41083011-semaglutide-v1","kind":"story-version","urls":{"story":"https://peptidescanner.com/stories/pubmed-pmid-41083011-semaglutide/","json":"https://peptidescanner.com/evidence/v1/objects/pubmed-pmid-41083011-semaglutide-v1.json","markdown":"https://peptidescanner.com/evidence/v1/objects/pubmed-pmid-41083011-semaglutide-v1.md"},"story":{"slug":"pubmed-pmid-41083011-semaglutide","version":1,"domain":"Literature metadata","dateInSource":"2026-06-29","sourceCheckedAt":"2026-07-30","publishedAt":"2026-08-14","peptideSlugs":["semaglutide"],"peptides":[{"slug":"semaglutide","url":"https://peptidescanner.com/peptides/semaglutide/"}]},"claims":[{"id":"headline","text":"Balancing oral sequential absorption barriers of semaglutide-loaded nanoparticles by optimization of surface glycocholic acid density.","sourceIds":["pubmed-observation-pmid-41083011-2026-06-29-34a9ec8bd4a4"]},{"id":"summary","text":"PubMed lists PMID 41083011 in Journal of controlled release : official journal of the Controlled Release Society as Journal Article, Research Support, Non-U.S. Gov't, with publication-date metadata of 2025-10-11 (day precision). PeptideScanner associated the retained record with the identity slug semaglutide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.","sourceIds":["pubmed-observation-pmid-41083011-2026-06-29-34a9ec8bd4a4"]},{"id":"paragraph-1","text":"PubMed lists PMID 41083011 in Journal of controlled release : official journal of the Controlled Release Society as Journal Article, Research Support, Non-U.S. Gov't, with publication-date metadata of 2025-10-11 (day precision). PeptideScanner associated the retained record with the identity slug semaglutide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.","sourceIds":["pubmed-observation-pmid-41083011-2026-06-29-34a9ec8bd4a4"]},{"id":"paragraph-2","text":"This page reproduces bounded bibliographic metadata attributed to PubMed. Its title and publication details are source metadata, not PeptideScanner's endorsement or an assertion of safety, efficacy, or scientific truth.","sourceIds":["pubmed-observation-pmid-41083011-2026-06-29-34a9ec8bd4a4"]}],"sources":[{"id":"pubmed-observation-pmid-41083011-2026-06-29-34a9ec8bd4a4","name":"PubMed","sourceClass":"A","title":"Balancing oral sequential absorption barriers of semaglutide-loaded nanoparticles by optimization of surface glycocholic acid density. · retained source version 1:2026-06-29:current:34a9ec8bd4a40f52ec7370dba17e894b245c25404247f07518af2adf9ce77b3a","url":"https://pubmed.ncbi.nlm.nih.gov/41083011/"}],"correction":{"state":"none"},"boundaries":{"scope":"selected-public-evidence-only","reporting":"PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.","unknowns":["Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.","This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.","This object does not determine safety, efficacy, causality, or suitability for any person."],"methodologyUrl":"https://peptidescanner.com/methodology/","medicalDisclaimerUrl":"https://peptidescanner.com/medical-disclaimer/"},"commitments":{"publicationLedgerSha256":"15e278ba70adf252e00548d9d8818c13c66cac3c4d6c75ae0ef0c88dc475efc7","tierARecordSha256":"53050ef5c274d91318269213e864a9ea7b36fd1e5ffaa2f954cd43d68fa91982"},"integrity":{"algorithm":"sha256","contentSha256":"f26075e2fe8e3fdb3007d54a7ef9bdfc91be2969f22f563f899352f3b51633c3"}}